Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
A different scope from Chemical Profiles, which picks out a specific, pre-chosen family of compounds (a phytochemistry-style approach). This section is for full metabolomics: an unbiased sweep of every metabolite detectable in a sample at once, meant to surface biochemical activity and pathway-level behavior that a narrowly targeted compound list would miss. This section provides real matched experimental-metabolomics studies (MetaboLights) and real genome-based metabolic-pathway inference (KEGG) for species with a genome already in this catalog — KEGG rows reflect which pathways a species' own annotated genes place it in, not experimentally measured metabolite presence, stated explicitly on every such row below.
Have data of this kind? How to contribute data →
MetaboLights: Decoding the Regulatory Networks of Proteus mirabilis Under Succinic Acid Stress: A Multi-Omics Approach (View at source ↗)AFDSI-METABPROF-275
MetaboLights: Harnessing microbial-derived metabolites in the urinary tract to prevent infection induced catheter encrustation (View at source ↗)AFDSI-METABPROF-276
MetaboLights: Bacterial profiles analysed by REIMS using Xevo G2-XS (View at source ↗)AFDSI-METABPROF-277
MetaboLights: Analysis of 3274 bacterial isolates by rapid evaporative ionisation mass spectrometry (REIMS) (View at source ↗)AFDSI-METABPROF-278
MetaboLights: Analysis of 3274 bacterial isolates by rapid evaporative ionisation mass spectrometry (REIMS) (View at source ↗)
MetaboLights: Mapping human microbiome drug metabolism by gut bacteria and their genes (View at source ↗)
KEGG: KEGG genome-based metabolic profile (phag) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (prq) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (pmag) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
MetaboLights: Mapping human microbiome drug metabolism by gut bacteria and their genes (View at source ↗)
MetaboLights: Analysis of 3274 bacterial isolates by rapid evaporative ionisation mass spectrometry (REIMS) (View at source ↗)AFDSI-METABPROF-285
MetaboLights: Harnessing microbial-derived metabolites in the urinary tract to prevent infection induced catheter encrustation (View at source ↗)AFDSI-METABPROF-283
MetaboLights: Mapping human microbiome drug metabolism by gut bacteria and their genes (View at source ↗)AFDSI-METABPROF-284
KEGG: KEGG genome-based metabolic profile (pvc) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
MetaboLights: Comparative metabolomics and transcriptomics revealed multiple pathways associated with polymyxin killing in Pseudomonas aeruginosa (View at source ↗)AFDSI-METABPROF-286
MetaboLights: Genome-scale metabolic modelling of responses to polymyxins in Pseudomonas aeruginosa (View at source ↗)AFDSI-METABPROF-287
MetaboLights: Metabolic Phenotyping and Strain Characterisation of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Using Rapid Evaporative Ionisation Mass Spectrometry (View at source ↗)AFDSI-METABPROF-288
MetaboLights: Exogenous glutamate potentiates gentamicin to kill multidrug- and carbapenem-resistant Pseudomonas aeruginosa through activating biosynthesis of unsaturated fatty acids (View at source ↗)AFDSI-METABPROF-289
MetaboLights: Transcriptomic and Metabolomics Profiling of Phage–Host Interactions between Phage PaP1 and Pseudomonas aeruginosa (View at source ↗)AFDSI-METABPROF-290
MetaboLights: Valine potentiates cefoperazone-sulbactam to kill methicillin resistant Staphylococcus aureus (View at source ↗)AFDSI-METABPROF-448
MetaboLights: A phosphoketolase bypasses reductive stress in P. aeruginosa under anaerobic survival (View at source ↗)AFDSI-METABPROF-449
KEGG: KEGG genome-based metabolic profile (pvg) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presenceAFDSI-METABPROF-384
KEGG: KEGG genome-based metabolic profile (pala) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presenceAFDSI-METABPROF-385
MetaboLights: Analysis of 3274 bacterial isolates by rapid evaporative ionisation mass spectrometry (REIMS) (View at source ↗)AFDSI-METABPROF-282
KEGG: KEGG genome-based metabolic profile (prg) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presenceAFDSI-METABPROF-389